Predictors of Locoregional Outcome in HER2-Overexpressing Breast Cancer Treated With Neoadjuvant ChemotherapyD.M. Arsenault, Jean L. Wright, Cristiane Takita et al.|American Journal of Clinical Oncology|2013Cited by 16
Prognostic Factors for Locoregional Recurrence in HER-2 Overexpressing Breast Cancer Patients Treated with Neoadjuvant ChemotherapyD.M. Arsenault, Jean L. Wright, Judith Hurley et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 1
Hormone Receptor Status Influences the Locoregional Benefit of Trastuzumab in Patients With Nonmetastatic Breast CancerD.M. Arsenault, Jean L. Wright|Breast Diseases A Year Book Quarterly|2013Cited by 1